Net profit up but revenue down for China's Sinopec as diesel demand falls
By Sherry Qin
China Petroleum & Chemical Corp. (HK:386) (CN:600028)reported a rise in its first-half net profit but lower revenue due to a decline in demand for diesel.
Net profit for the first six months ended June rose 1.7% to 35.70 billion yuan, equivalent to $5.01 billion, while revenue fell 1.1% from a year earlier to 1.576 trillion yuan, the Chinese state-owned oil-and-gas major, also known as Sinopec, said Sunday.
Capital expenditure totaled 55.89 billion yuan and was mainly used for crude and natural gas production, it said.
Sinopec said sales of petroleum products, which make up more than half of its revenue, came in at CNY920.4 billion, 0.6% lower on year mainly due to lower diesel sales.
The company plans to use between CNY800 million and CNY15 billion of its funds to repurchase A shares to "bring the company's stock market price into line with its intrinsic value," it said in a separate filing. The company has been repurchasing its A and H shares since November.
Sinopec expects domestic demand for natural gas and chemical products to continue growing in the second half of the year while the refined oil demand may remain stable.
Two other major Chinese oil producers, CNOOC (HK:883) and PetroChina (HK:857), are scheduled to report their results next week.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-25-24 2158ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks